Primary Vitamin D Target Genes Allow a Categorization of Possible Benefits of Vitamin D3 Supplementation

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Carlberg, Carsten ^a   Seuter, Sabine ^a   de Mello, Vanessa D F ^a   Schwab, Ursula ^a,b   Voutilainen, Sari ^a   Pulkki, Kari ^a   Nurmi, Tarja ^a   Virtanen, Jyrki ^a   Tuomainen, Tomi Pekka ^a   Uusitupa, Matti ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; CD14 ANTIGEN; COLECALCIFEROL; GLUCOSE; INTERLEUKIN 6; MESSENGER RNA; PARATHYROID HORMONE; PLACEBO; THROMBOMODULIN; VITAMIN D;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; CD14 GENE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DOSE COMPARISON; DRUG MEGADOSE; FEMALE; FINLAND; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PERIPHERAL BLOOD MONONUCLEAR CELL; SIGNAL TRANSDUCTION; THBD GENE; TREATMENT DURATION; TREATMENT RESPONSE; UPREGULATION; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; WINTER;

ADIPOSE TISSUE; AGED; ANTIGENS, CD14; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; SEASONS; SIGNAL TRANSDUCTION; THROMBOMODULIN; VITAMIN D DEFICIENCY;

EID: 84880809412     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071042     Document Type: Article

References (47)

1. Holick MF, Frommer JE, McNeill SC, Richtand NM, Henley JW, et al. (1977) Photometabolism of 7-dehydrocholesterol to previtamin D3 in skin. Biochem Biophys Res Commun 76: 107-114.
2. Haussler MR, Jurutka PW, Mizwicki M, Norman AW, (2011) Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)2vitamin D3: genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab 25: 543-559.
3. Carlberg C, Campbell MJ, (2013) Vitamin D receptor signaling mechanisms: Integrated actions of a well-defined transcription factor. Steroids 78: 127-136.
4. Carlberg C, Molnár F, (2012) Current status of vitamin D signaling and its therapeutic applications. Curr Top Med Chem 12: 528-547.
5. Hollis BW, (2005) Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr. 135: 317-322.
6. Institute-of-Medicine (2011) Dietary reference intakes for calcium and vitamin D. Washington, DC: National Academies Press.
7. Holick MF, (2007) Vitamin D deficiency. N Engl J Med 357: 266-281.
8. Holick MF, (2011) Vitamin D deficiency in 2010: health benefits of vitamin D and sunlight: a D-bate. Nat Rev Endocrinol 7: 73-75.
9. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, et al. (2008) Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 29: 726-776.
10. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM, (2001) Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358: 1500-1503.
11. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, et al. (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117: 503-511.
12. Giovannucci E, Liu Y, Hollis BW, Rimm EB, (2008) 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 168: 1174-1180.
13. Rosen CJ, Adams JS, Bikle DD, Black DM, Demay MB, et al. (2012) The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev 33: 456-492.
14. Garland CF, Gorham ED, Mohr SB, Garland FC, (2009) Vitamin D for cancer prevention: global perspective. Ann Epidemiol 19: 468-483.
15. Pandita KK, Razdan S, Kudyar RP, Beigh A, Kuchay S, et al. (2012) Excess gooD can be Dangerous. A case series of iatrogenic symptomatic hypercalcemia due to hypervitaminosis D. Clin Cases Miner Bone Metab 9: 118-120.
16. Bischoff-Ferrari HA, Shao A, Dawson-Hughes B, Hathcock J, Giovannucci E, et al. (2010) Benefit-risk assessment of vitamin D supplementation. Osteoporos Int 21: 1121-1132.
17. DeLuca HF, (2004) Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 80: 1689S-1696S.
18. Ingraham BA, Bragdon B, Nohe A, (2008) Molecular basis of the potential of vitamin D to prevent cancer. Curr Med Res Opin 24: 139-149.
19. Verstuyf A, Carmeliet G, Bouillon R, Mathieu C, (2010) Vitamin D: a pleiotropic hormone. Kidney Int 78: 140-145.
20. Ramagopalan SV, Heger A, Berlanga AJ, Maugeri NJ, Lincoln MR, et al. (2010) A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res 20: 1352-1360.
21. Heikkinen S, Väisänen S, Pehkonen P, Seuter S, Benes V, et al. (2011) Nuclear hormone 1α,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy. Nucleic Acids Res 39: 9181-9193.
22. Kovalenko PL, Zhang Z, Cui M, Clinton SK, Fleet JC, (2010) 1,25 dihydroxyvitamin D-mediated orchestration of anticancer, transcript-level effects in the immortalized, non-transformed prostate epithelial cell line, RWPE1. BMC Genomics 11: 26.
23. Hossein-Nezhad A, Spira A, Holick MF, (2013) Influence of vitamin D status and vitamin D3 supplementation on genome wide expression of white blood cells: a randomized double-blind clinical trial. PLoS One 8: e58725.
24. Meyer MB, Goetsch PD, Pike JW, (2012) VDR/RXR and TCF4/β-catenin cistromes in colonic cells of colorectal tumor origin: iImpact on c-FOS and c-MYC gene expression. Mol Endocrinol 26: 37-51.
25. Carlberg C, Seuter S, Heikkinen S, (2012) The first genome-wide view of vitamin D receptor locations and their mechanistic implications. Anticancer Res 32: 271-282.
26. Engelman CD, Meyers KJ, Iyengar SK, Liu Z, Karki CK, et al. (2013) Vitamin D intake and season modify the effects of the GC and CYP2R1 genes on 25-hydroxyvitamin D concentrations. J Nutr 143: 17-26.
27. Engelman CD, Fingerlin TE, Langefeld CD, Hicks PJ, Rich SS, et al. (2008) Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. J Clin Endocrinol Metab 93: 3381-3388.
28. Orton SM, Morris AP, Herrera BM, Ramagopalan SV, Lincoln MR, et al. (2008) Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. Am J Clin Nutr 88: 441-447.
29. Snellman G, Melhus H, Gedeborg R, Olofsson S, Wolk A, et al. (2009) Seasonal genetic influence on serum 25-hydroxyvitamin D levels: a twin study. PLoS One 4: e7747.
30. Tuomainen TP, Voutilainen S, Virtanen J, Nurmi T, Mursu J,et al. (2013) Glucose metabolism effects of vitamin D supplementation in prediabetes - the VitDmet study. submitted.
31. Nurmi T, Tuomainen TP, Virtanen J, Mursu J, Voutilainen S, (2013) High-performance liquid chromatography and coulometric electrode array detector in serum 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 analyses. Anal Biochem 435: 1-9.
32. de Mello VD, Erkkila AT, Schwab US, Pulkkinen L, Kolehmainen M, et al. (2009) The effect of fatty or lean fish intake on inflammatory gene expression in peripheral blood mononuclear cells of patients with coronary heart disease. Eur J Nutr 48: 447-455.
33. Kolehmainen M, Salopuro T, Schwab US, Kekalainen J, Kallio P, et al. (2008) Weight reduction modulates expression of genes involved in extracellular matrix and cell death: the GENOBIN study. Int J Obes 32: 292-303.
34. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: R34.
35. Vieth R, (2011) Why the minimum desirable serum 25-hydroxyvitamin D level should be 75 nmol/L (30 ng/ml). Best Pract Res Clin Endocrinol Metab 25: 681-691.
36. Mackey SL, Heymont JL, Kronenberg HM, Demay MB, (1996) Vitamin D receptor binding to the negative human parathyroid hormone response element does not require the retinoid X receptor. Mol Endocrinol 10: 298-305.
37. Liu SM, Koszewski N, Lupez M, Malluche HH, Olivera A, et al. (1996) Characterization of a response element in the 5'-flanking region of the avian (chicken) PTH gene that mediates negative regulation of gene transcription by 1,25-dihydroxyvitamin D3 and binds the vitamin D3 receptor. Mol Endocrinol 10: 206-215.
38. Outila TA, Kärkkäinen MUM, Lamberg-Allardt CJE, (2001) Vitamin D status affects serum parathyroid hormone concentrations during winter in female adolescents: associations with forearm bone mineral density. Am J Clin Nutr 74: 206-210.
39. Seuter S, Heikkinen S, Carlberg C, (2013) Chromatin acetylation at transcription start sites and vitamin D receptor binding regions relates to effects of 1α,25-dihydroxyvitamin D3 and histone deacetylase inhibitors on gene expression. Nucleic Acids Res 41: 110-124.
40. Standahl Olsen K, Rylander C, Brustad M, Aksnes L, Lund E (2013) Plasma 25 hydroxyvitamin D level and blood gene expression profiles: a cross-sectional study of the Norwegian Women and Cancer Post-genome Cohort. Eur J Clin Nutr. in press.
41. McGeough MD, Pena CA, Mueller JL, Pociask DA, Broderick L, et al. (2012) Cutting edge: IL-6 is a marker of inflammation with no direct role in inflammasome-mediated mouse models. J Immunol 189: 2707-2711.
42. Zhang Y, Leung DY, Richers BN, Liu Y, Remigio LK, et al. (2012) Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol 188: 2127-2135.
43. Slattery ML, Wolff RK, Herrick JS, Caan BJ, Potter JD, (2007) IL6 genotypes and colon and rectal cancer. Cancer Causes Control 18: 1095-1105.
44. Kristiansen OP, Mandrup-Poulsen T, (2005) Interleukin-6 and diabetes: the good, the bad, or the indifferent? Diabetes 54Suppl 2: S114-124.
45. Sarwar N, Butterworth AS, Freitag DF, Gregson J, Willeit P, et al. (2012) Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet 379: 1205-1213.
46. Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, et al. (2010) Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376: 180-188.
47. Dastani Z, Li R, Richards B, (2013) Genetic regulation of vitamin D levels. Calcif Tissue Int 92: 106-117.